e-learning
resources
Vienna 2012
Monday, 03.09.2012
Quality of life and clinical parametres in monitoring airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
New GOLD 2011 guidelines: Is there an improvement?
A.S. Santos, R. Coelho, S. Granadeiro, R. Rosa, A. Borba, I. Gonçalves, P. Cravo, A. Mineiro, S. Coelho, M.J. Gomes, J. Cardoso (Lisbon, Portugal)
Source:
Annual Congress 2012 - Quality of life and clinical parametres in monitoring airway diseases
Session:
Quality of life and clinical parametres in monitoring airway diseases
Session type:
Thematic Poster Session
Number:
2283
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A.S. Santos, R. Coelho, S. Granadeiro, R. Rosa, A. Borba, I. Gonçalves, P. Cravo, A. Mineiro, S. Coelho, M.J. Gomes, J. Cardoso (Lisbon, Portugal). New GOLD 2011 guidelines: Is there an improvement?. Eur Respir J 2012; 40: Suppl. 56, 2283
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Lane-hamilton syndrome and CCF: a fatal association
Related content which might interest you:
The same COPD patients, different GOLD criteria – what are the consequences of changing GOLD 2007-2011-2017 recommendations?
Source: International Congress 2018 – Epidemiology of COPD : from exarcebations and comorbidities to asthma-COPD overlap syndrome (ACOS)
Year: 2018
GOLD 2011 versus GOLD 2017 – What does change?
Source: International Congress 2017 – Classifying COPD with multidimensional scores and biomarkers
Year: 2017
Differences in the recommended initial therapy of COPD according to GOLD guidelines 2006 and 2011
Source: Annual Congress 2012 - GOLD guidelines 2011: new assessment of COPD
Year: 2012
Evaluating the use of the Australian and New Zealand COPD guidelines (The COPD-X Plan) in clinical practice: a user survey
Source: Virtual Congress 2020 – Evaluation of knowledge transfer into clinical practice
Year: 2020
Simply the best: the 2004 ERS/ATS web guidelines for management of COPD
Source: ISSN=ISSN 1810-6838, ISBN=, page=11
Year: 2004
2015 guidelines to treat IPF: an update from the 2011 guidelines - METHODOLOGY
Source: International Congress 2015 – Treatment of idiopathic pulmonary fibrosis
Year: 2015
The 2013 updated GOLD strategy: A comparison of the various scenarios
Source: International Congress 2014 – Best abstracts in chronic care
Year: 2014
Results of a pulmonary rehabilitation program (PRP) in COPD patients: Differences in outcomes according to currently 2011 GOLD groups
Source: International Congress 2014 – Best posters in pulmonary rehabilitation 2
Year: 2014
Assessment of patients with COPD according to previous and new GOLD: Which stage in which group?
Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care
Year: 2014
2015 guidelines to treat IPF: an update of the 2011 guidelines - specific treatment recommendations
Source: International Congress 2015 – Treatment of idiopathic pulmonary fibrosis
Year: 2015
Global asthma physician & patient (GAPP) survey: differences between treatment practice and GINA guideline recommendations in Europe – paediatric findings
Source: Eur Respir J 2006; 28: Suppl. 50, 480s
Year: 2006
Changes in GOLD Classifications: 2011 versus 2017. Do exacerbations have any role in mortality?
Source: International Congress 2017 – COPD management: new findings from large studies
Year: 2017
ERJ September Podcast: Updating the GINA guidelines for asthma control
Source: Eur Respir J 2015; 46: E57
Year: 2015
Global asthma physician & patient (GAPP) survey: differences between treatment practice and GINA guideline recommendations in Europe – adult findings
Source: Annual Congress 2006 - New developments in the management of asthma
Year: 2006
Management of stable COPD: Are GOLD recommendations fully applied?
Source: Annual Congress 2010 - COPD: management
Year: 2010
COPD classification according GOLD 2013 and Latin American Thoracic Association (ALAT) recommendations in PUMA study
Source: International Congress 2016 – Prevalence of obstructive airway diseases, methods of diagnosis, and lung function testing
Year: 2016
May 29: New opportunities for clinical research consortia in Severe Asthma and COPD and what is required of a successful Expression of Interest for the 2008 IMI calls?
Source:
Year: 2008
An old disease from a new perspective – GOLD 2011 recommendations for COPD
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012
Learn from the past and create the future: the 2013 ATS/ERS statement on pulmonary rehabilitation
Source: Eur Respir J 2013; 42: 1169-1174
Year: 2013
Health status in the GOLD guidelines era. Assessing the new COPD severity staging criteria
Source: Eur Respir J 2002; 20: Suppl. 38, 251s
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept